User profiles for Nisreen M.A. Okba
 | Nisreen OkbaPostdoctoral researcher, Icahn School of Medicine at Mount Sinai Verified email at mssm.edu Cited by 10387 |
[HTML][HTML] Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches
Highlights • MERS-CoV vaccines for dromedary camels and their human contacts can
potentially stop virus transmission in the community. • Both neutralizing antibody and T-cell …
potentially stop virus transmission in the community. • Both neutralizing antibody and T-cell …
[HTML][HTML] MERS-coronavirus: From discovery to intervention
Middle East respiratory syndrome coronavirus (MERS-CoV) still causes outbreaks despite
public awareness and implementation of health care measures, such as rapid viral diagnosis …
public awareness and implementation of health care measures, such as rapid viral diagnosis …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
[HTML][HTML] A human monoclonal antibody blocking SARS-CoV-2 infection
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused
a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted …
a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted …
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had a large impact on global health, travel, and economy. Therefore, preventative and …
had a large impact on global health, travel, and economy. Therefore, preventative and …
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
…, G van Amerongen, J van den Brand, NMA Okba… - Science, 2020 - science.org
The current pandemic coronavirus, severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2),
was recently identified in patients with an acute respiratory syndrome, coronavirus …
was recently identified in patients with an acute respiratory syndrome, coronavirus …
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome
SARS-CoV-2 has been identified as the causative agent of a global outbreak of respiratory
tract disease (COVID-19). In some patients, the infection results in moderate to severe acute …
tract disease (COVID-19). In some patients, the infection results in moderate to severe acute …
[HTML][HTML] SARS-CoV-2 is transmitted via contact and via the air between ferrets
SARS-CoV-2, a coronavirus that emerged in late 2019, has spread rapidly worldwide, and
information about the modes of transmission of SARS-CoV-2 among humans is critical to …
information about the modes of transmission of SARS-CoV-2 among humans is critical to …
[HTML][HTML] An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
CH GeurtsvanKessel, NMA Okba, Z Igloi… - Nature …, 2020 - nature.com
The world is entering a new era of the COVID-19 pandemic in which there is an increasing
call for reliable antibody testing. To support decision making on the deployment of serology …
call for reliable antibody testing. To support decision making on the deployment of serology …
Convalescent plasma for COVID-19. A randomized clinical trial
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …